Welcome to OVG
The Oxford Vaccine Group has been at the forefront of vaccine development for 30 years, helping to fight diseases of major global importance through research and education around the world.
What's Happening?
30 Years of OVG
1994 - 2024
Join our celebrations and learn about 30 years of ground-breaking research at OVG
Study Spotlight
| BiVISTA👤 18 to 55 years old 📅 24 to 31 visits over 7 months 💉1 vaccination and 1 challenge 🧬 Could you be a part of the battle against Typhoid and Paratyphoid fever? 🪙 Up to £4585 reimbursement |
Be a Vaccine Hero
Take part in a study
Could you be a Vaccine Hero by taking part in one of our clinical trials? Find out about the trials and studies currently looking for volunteers, as well as what it is like taking part from previous participants
Study - MUCOSAL
Help us investigate the response of cells in the nose, lung and blood after respiratory infections.
Study - ECLIPSE
A study to understand how the body reacts to a combination of the flu virus and pneumococcal bacteria.
Study - BIO-005
Help us find a safe and effective malaria vaccine!
Research at OVG
Education, Learning and Public Involvement
Latest Publications
⠀⠀⠀⠀⠀
-
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines.
Journal article
Murray SM. et al, (2025), Sci Immunol, 10
-
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.
Journal article
Amini A. et al, (2025), Sci Immunol, 10
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006).
Journal article
Li G. et al, (2025), Vaccine, 62
-
Novel and optimized diagnostics for pediatric TB in endemic countries: NOD-pedFEND study protocol.
Journal article
Song R. et al, (2025), BMC Pediatr, 25
Working Together
National Immunisation Schedule Evaluation Consortium II
OVG is proud to lead NISEC II, a collaboration between a network of Academic Clinical Research groups and the UK Health Security Agency.
Immune Memory and Mechanisms of Protection from Vaccines
Oxford is proud to host the IMMPROVE consortium of universities, government, industry and others.
